News and Industry Information

Acuamark Diagnostics, Announces Change to Its Board of Directors

July 23, 2020

July 22, 2020

Acuamark Diagnostics, Announces Change to Its Board of Directors

NEW YORK — July 21, 2020 — Acuamark Diagnostics, Inc. (“AcuamarkDx”), a biotechnology company that focuses on developing innovative blood-based screening assays for reliable and cost-effective detection of early-stage cancer, today announced the appointment of William Gedale as its Executive Chairman. Mr. Gedale will replace Mr. Michael Gargano as Chairman of the Company.

Click here for more information

Leave a Reply

Your email address will not be published. Required fields are marked *

CURRENT AND PREVIOUS CLIENTS

Get Our Newsletter

Stay up to date with news and deals